Document is current
Any future updates will be listed below
-
Authors
Wetzel, Ethan A.
Nohman, Amin I.
Hsieh, Annie L.
Reuss, David
Unterberg, Andreas W.
Eyüpoglu, Ilker Y.
Hua, Lingyang
Youssef, Gilbert
Wen, Patrick Y.
Cahill, Daniel P.
Jungk, Christine
Juratli, Tareq A.
Miller, Julie J.
-
Funding
Funding for this research was provided by:
NINDS (K08NS119796)
- License Information
-
More Information
Article History
Received: 11 September 2024
Accepted: 3 October 2024
First Online: 21 October 2024
Declarations
:
: D. P. C reports grants from NIH and Tawingo Fund during the conduct ofthe study; financial compensation from Servier, Boston Scientific and Pyramid Biosciences for advisory input. PYW reports research support from Astra Zeneca, Black Diamond, Bristol Meyers Squibb, Celgene, Chimerix, Eli Lily, Erasca, Genentech/ Roche, Kazia, MediciNova, Merck, Novartis, Nuvation Bio, Servier, Vascular Biogenics, VBI Vaccines; personal fees from Astra Zeneca, Black Diamond, Celularity, Chimerix, Day One Bio, Genenta, Glaxo Smith Kline, Merck, Mundipharma, Novartis, Novocure, Nuvation Bio, Prelude Therapeutics, Sapience, Servier, Sagimet, Vascular Biogenics, VBI Vaccines. T.A.J. received honoraria from CSL Behring. J.J.M. reports grants from the National Institute of Neurological Diseases and Stroke, American Cancer Society, Seeman Family Funds, National Cancer Institute, and MGH Transformative Scholar Award during the conduct of the study; personal fees from Servier.
